Pioneering RNA editing to deliver the future of medicine.
OUR SCIENCE
A one letter difference.
A whole new story.
RNA editing holds great promise to rewrite what’s possible for patients. Since the discovery of the first generation of editing technologies, researchers have been working to overcome the inherent complexity of these initial approaches to develop viable new treatments for patients.
Our foundational platform for RNA editing – Oligonucleotide Promoted Editing of RNA (OPERA) – is inspired by the elegance and simplicity of the natural processes that many species, including humans, use to make transient, reversible changes to genetic instructions
READ MORE
About us
We work different.
Korro Bio was founded from our drive to find new pathways to what’s possible. Our team is committed to turning extraordinary scientific insights into life-changing new treatments for people with debilitating and life-threatening diseases.
Discover MORE - PRESS RELEASE 12/07/2023 READ ALL PRESS RELEASES
-
Publications
02/25/2023
Development of a selection assay for small guide RNAs that drive efficient site-directed RNA editing
READ ALL Publications
Join us
Write the next chapter of your career.
Do you like to look at things differently? We take historically complex methodologies and strip them down to their most basic science to deliver sophisticated therapies for those with debilitating disease. If you share our vision, we invite you to join us on this journey.
Explore opportunities